Key facts
- Catalyst OrthoScience’s last known valuation is $43.4M (Sep 2023).
- It has raised $86.6M across 5 recorded rounds; the latest was Seed Round ($4.1M) in Jul 2025.
- Notable investors include Lateral Capital Management, Tamiami Angel Funds, RC Capital (Cincinnati), Bridge Bank, Derace Schaffer — 10 tracked in total.
- Catalyst OrthoScience has filed 7 Form Ds with the SEC since 2015, most recently Jul 2025 ($4.1M sold to 3 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Catalyst OrthoScience
Funding rounds
5 roundsAbout Catalyst OrthoScience
Developer of a shoulder replacement system designed to make orthopedic surgery less invasive and more efficient. The company's system is fixed without a stem to preserve as much strong, healthy bone as possible, replacing traditional shoulder implants, which required removal of the top of the humerus so a stem could be inserted down into the bone canal, enabling patients to get access to a precisely less-invasive alternative method of shoulder implant placement.
- Sector
- Healthcare
- HQ
- Naples, FL, United States
- Founded
- 2014
- Employees
- 52
- Website
- catalystortho.com/
- Ownership
- Privately Held (backing)
Catalyst OrthoScience doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Catalyst OrthoScience shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Catalyst OrthoScience in its N-PORT filings yet. We sweep new filings monthly.